IMSTAR Dx will present an oral communication on November 16th, 2022, at 2 pm in room 241, during the Breast Pathology and Artificial Intelligence session under the title of :
Automated evaluation of Ki67 and HER2 markers in breast cancer and Ki67 in Neuroendocrine Tumors, through quantitative image analysis and AI- Machine Learning.
The study from which this presentation stemmed was carried out as part of an ongoing collaboration with the AFAQAP, the French Association for Pathology Assurance Quality.
We are looking forward to discussing the subject with you.
For more information on PathoScan T/C Markers.
